Kite Pharma

Share on: 
Community College Hire
Website: Kite Pharma

Kite Pharma is developing engineered autologous T cells that express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. The platform has the potential to address both hematological and solid tumor cancers.


Internship Page(s): 
Kite Pharma, Inc.
Santa Monica CA
United States